ABOUT AUGUST BIOSERVICES
August Bioservices is a growing, U.S.-based contract development and manufacturing organization (CDMO) specializing in sterile injectable formulation and fill/finish cGMP manufacturing. We support both large and small molecules, delivered through aseptic processing at clinical and commercial scales.
August Bioservices offers a wide range of integrated capabilities, supported by an experienced cross-functional team focused on quality, efficiency, and an unmatched focus on helping our clients achieve their program goals. Our expertise spans formulation development, analytical testing, and scalable fill/finish solutions designed to meet the needs of programs at clinical phases through the manufacture of commercial supply.
Capabilities include:
- Formulation development
- cGMP analytical laboratories
- State-of the-art, isolated cGMP filling lines to accommodate a wide range of container types and batch sizes
- Automated inspection, packaging, labeling, serialization, and shipping
- Qualified, experienced, and collaborative project teams
KEY DIFFERENTIATORS
- Flexible capacity to support both clinical and commercial manufacturing
- Formulation scale from 1 L to 4000 L
- State-of-the-art, isolated Optima vial filler and syringe filler
- Automated visual inspection, assembly, labeling, packaging, and serialization
- On-site warehouse, cold room, and DEA schedule III-V storage
- Wide range of fill/finish capabilities across multiple container types and sizes, including:
- Vials 2 mL to 100 mL
- IV Bags: 50 mL to 2 L
- Syringes/Cartridges: 1mL to 10 mL
- Experienced leadership and technical teams with a strong track record of supporting products from development through commercial launch across geographic regions
FEATURED ARTICLES
-
![GettyImages-1439394099-vial-aspetic-filling-glove]( "Handling Demanding Active Ingredients Safely And Efficiently")
Handling Demanding Active Ingredients Safely And EfficientlySee three flexible Optima fill‑finish and syringe assembly systems to boost performance, accuracy, and scalability, enabling efficient processing of diverse formats and supporting rapid CDMO growth.
-
![AugustBio_Reshoring_Fixed]( "How Reshoring, GLP-1s, And Supply Chain Security Are Transforming CDMOs")
How Reshoring, GLP-1s, And Supply Chain Security Are Transforming CDMOsExplore how reshoring, GLP-1 capacity demands, and integrated U.S.-based manufacturing models are reshaping CDMO partnerships in a rapidly evolving pharmaceutical market.
-
![AugustBio_Hiring_Fixed]( "Strategic Hiring For Scalable Success")
Strategic Hiring For Scalable SuccessDiscover how a people-first talent strategy, purpose-driven culture, and cross-functional collaboration come together to support scalable growth and operational excellence in commercial manufacturing.
-
![AugustBio_Investing_Fixed]( "Operational Success By Strategic Investment")
Operational Success By Strategic InvestmentExplore how infrastructure, equipment strategy, and advanced technologies shape a more reliable path for scaling sterile injectable programs.
-
![AugustBio_Scaling_Fixed]( "Scaling With The Client In Mind: A Customer-Centric Approach To Project Scale-Up")
Scaling With The Client In Mind: A Customer-Centric Approach To Project Scale-UpIn today’s fast-moving biopharma landscape, scaling from clinic to commercial takes more than expertise. See how collaboration can transform scale-up and drive confident progress
-
![GettyImages-1214112149-lab-team-collaboration-research]( "How Strong Intellectual Property Laws Keep Tennessee's Health Innovation Humming")
How Strong Intellectual Property Laws Keep Tennessee's Health Innovation HummingStrong IP protections drive Tennessee’s biotech growth by attracting investment, supporting research, fostering collaboration, and enabling innovators to deliver new therapies and technologies to patients.
-
![GettyImages-1404945060-lab-process-cleanroom-research]( "Three Trends To Know Before Selecting Your CDMO")
Three Trends To Know Before Selecting Your CDMOLearn more about the desire for deeper collaboration between innovator companies and their CDMO partners and why companies are seeking robust drug development capabilities in-house.
-
![GettyImages-1393951695-IV-bag-intravenous]( "Bag Flling Is Now Possible In The United States")
Bag Flling Is Now Possible In The United StatesExplore the reasons why one CDMO is expanding its operations to offer flexible bag filling, after being equipped with filling lines for PFS and glass vials (glass or plastic).
-
![iStock-136140244-lab-pharma-equipment-process]( "Transitioning From Clinical Phases To Commercial Readiness")
Transitioning From Clinical Phases To Commercial ReadinessRyan Downey, Director of Customer Operations, Commercial Development, offers several insights as to why August Bioservices has become one of the most sought-after and fastest-growing CDMOs in the industry.
AUGUST BIOSERVICES AWARDS
CONTACT INFORMATION
August Bioservices
1845 Elm Hill Pike
Nashville, TN 37210
UNITED STATES
Phone: (615) 515-5400
Contact: Jaeda Marshall, jmarshall@augustbio.com
FEATURED SOLUTIONS
WEBINARS
"One stop” sterile injectable fill/finish capabilities can accelerate timelines and reduce costs. Explore August Bio’s operational flexibility and available capacity to support small-, mid-size, and large-scale batches.